Literature DB >> 3943003

The infrahyoid myocutaneous flap for reconstruction after resection of head and neck cancer.

H S Wang, J W Shen, D B Ma, J D Wang, A L Tian.   

Abstract

From May 1979 to August 1984, 112 infrahyoid myocutaneous flaps (IHMCFs) were used for reconstruction of the tongue after resection of lingual carcinoma (67 flaps in 63 consecutive cases) and for repair of defects after resection of carcinomas of buccal mucosa (23 cases), floor of mouth (8 cases), parotid gland (7 cases), and other malignancies (7 cases). Ten IHMCFs were extended to Ludwig's angle for repairing the open defect of the cheek or combined defect in the buccal mucosa and hard palate. The donor sites of 76 IHMCFs could be sutured primarily. The flap was successful in 90% of the cases (101 of 112 cases). Postoperatively, 94% of the cases (60 of 64 cases) of reconstructed tongue had good deglutition and 78% of the cases (50 of 64 cases) gave satisfactory enunciation. IHMCF is a new, versatile, reliable, and convenient flap suitable for repairing the defects in and around the oral cavity, particularly in the tongue, even in aged and weak patients.

Entities:  

Mesh:

Year:  1986        PMID: 3943003     DOI: 10.1002/1097-0142(19860201)57:3<663::aid-cncr2820570344>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Re-use of pectoralis major myocutaneous flap for the treatment of recurrent hypopharyngeal stenosis following total laryngectomy and postoperative radiotherapy: a case report.

Authors:  Christophe Van Haverbeke; Georges Lawson; Marc Remacle
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-12       Impact factor: 2.503

2.  Infrahyoid muscle flap for pharyngeal fistulae after cervical spine surgery: a novel approach--report of six cases.

Authors:  Rainer O Seidl; Andreas Niedeggen; Ingo Todt; Martin Westhofen; Arne Ernst
Journal:  Eur Spine J       Date:  2006-08-22       Impact factor: 3.134

3.  Infrahyoid myocutaneous flap reconstruction after wide local excision of a Merkel cell carcinoma.

Authors:  A Deganello; R De Bree; G Dolivet; C R Leemans
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

4.  Infrahyoid Myofasciocutaneous Flap for Reconstruction of Tongue Defects: Our Experience and Perspective.

Authors:  Hemanth Varma; R Yeshwanth; B V Prakash; Zuhaib Mohammed
Journal:  Indian J Surg Oncol       Date:  2019-05-16

5.  Anatomical study and modified incision of the infrahyoid myocutaneous flap.

Authors:  Dian Ouyang; Xuan Su; Wei-Chao Chen; Yan-Feng Chen; Qian-Qian Men; An-Kui Yang
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-26       Impact factor: 2.503

6.  The musculocutaneous infrahyoid flap: surgical key points.

Authors:  Haïtham Mirghani; Gustavo Meyer; Stéphane Hans; Gilles Dolivet; Sophie Périé; Daniel Brasnu; Jean Lacau St Guily
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

7.  Infrahyoid myofascial flap for tongue reconstruction.

Authors:  Jochen P Windfuhr; Stephan Remmert
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-26       Impact factor: 2.503

8.  Infrahyoid flap in oropharyngeal reconstruction following carcinoma resection: A study of 6 patients and literature review.

Authors:  Pedro Infante-Cossio; Eduardo Gonzalez-Cardero; Ricardo Lopez-Martos; Victoria Nuñez-Vera; Erika Olmos-Juarez; Alejandro Ruiz-Moya; Juan-Jose Haro-Luna; Eusebio Torres-Carrranza
Journal:  Oncol Lett       Date:  2016-04-07       Impact factor: 2.967

9.  Infrahyoid Flap, a Convenient Alternative for Reconstruction of Tongue and Floor of Mouth Defects: Case Series.

Authors:  Akif İşlek; Mustafa Koray Balcı; Özlem Yüksel; Kazım Önal; Seçil Arslanoğlu; Erdem Eren
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

10.  A study of anatomical variability of the omohyoid muscle and its clinical relevance.

Authors:  Rajalakshmi Rai; Anu Ranade; Soubhagya Nayak; Rajanigandha Vadgaonkar; Pai Mangala; Ashwin Krishnamurthy
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.